Tandem Diabetes Care, Inc.

Healthcare

NASDAQ:TNDM · NASDAQ Global Market

Market Cap $1.06B Beta 1.57 P/E (TTM) -11.3

$15.30 +1.53%

+$0.24 today

52W Low $9.98High $29.65

Vol 2.51M · Avg 2.43M

EPS (TTM) -$1.38Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-24.33%

Period High

$28.26

Period Low

$10.12

Latest

$15.30

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Tango Therapeutics, Inc.

NASDAQ:TNGX

$3.53B

Kodiak Sciences Inc.

NASDAQ:KOD

$1.87B

UroGen Pharma Ltd.

NASDAQ:URGN

$1.58B

Septerna, Inc.

NASDAQ:SEPN

$1.58B

Nurix Therapeutics, Inc.

NASDAQ:NRIX

$1.49B

Fortrea Holdings Inc.

NASDAQ:FTRE

$1.44B

Integra LifeSciences Holdings Corporation

NASDAQ:IART

$1.39B

EyePoint Pharmaceuticals, Inc.

NASDAQ:EYPT

$1.13B

Phathom Pharmaceuticals, Inc.

NASDAQ:PHAT

$853.16M

InMode Ltd.

NASDAQ:INMD

$813.43M

What is the latest TNDM filing?

The latest filing shown is 4 dated Jun 4, 2026.

How many recent filings does TNDM have?

Intrinsic Alpha currently shows 20 recent filings for TNDM.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.